C07C 217 - Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton

Patents for C07C 217 - Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton (13,958)
12/2001
12/13/2001	WO2001093653A2 Ester quaternary mixtures
12/13/2001	WO2001072667A3 Modifying chemoselectivity during oxidation of nitrogen compounds
12/13/2001	WO2001044200A3 Selective neurokinin antagonists
12/13/2001	US20010051749 Reacting where the aniline group of the aminophenol is in the form of an anilide group; amide group is not cleaved or alkylated; direct reaction of protected phenol without independent deprotecting step, using alkyl halide
12/13/2001	US20010051158 A monoclonal antibody that specifically recognizes a stimulant or hallucinogenic drug of abuse or a metabolite, selected from d-methamphetamine, d-amphetamine, 3,4-methylenedioxymethamphetamine or derivatives
12/13/2001	DE10032134C1 Compositions for oxidative dyeing of keratinic fibers, especially human hair, comprise new or known 2-hydroxy-5-amino-biphenyl derivatives as developers
12/13/2001	DE10028453A1 Esterquat mixtures, used in production of cosmetic formulations for hair and skin contain esterquats derived from fatty acids with different chain lengths, e.g. coconut fatty acids and stearic and/or behenic acid
12/13/2001	CA2410409A1 Antitumoral compounds
12/12/2001	EP1162193A1 Acrylenediamine derivatives and organic electroluminescence device containing the same
12/12/2001	EP0968175B1 Spiro compounds and the use thereof
12/12/2001	EP0810201B1 Preventive/remedy for liver disease
12/12/2001	EP0781126B1 Derivatives of 2-amino-1,2,3,4-tetrahydro-naphthalene active on the cardiovascular system
12/12/2001	CN1326231A Hole transferring agent and photoelectric conversing device containing it
12/12/2001	CN1325845A Solidized hybridized vinyl ether containing electron providing compound
12/11/2001	US6329552 Malaria, schistosomiasis
12/11/2001	US6329551 High temperature stability
12/11/2001	US6329409 Amine derivatives and skin preparations for external use containing the same
12/11/2001	US6329399 Antifungal amine derivatives and processing for producing the same
12/06/2001	WO2001044167A8 Quaternary ammonium compounds and their use as anti-tussive agents
12/05/2001	EP1160888A1 Hole transporting agents and photoelectric conversion device comprising the same
12/05/2001	EP1159261A2 Antizyme modulators and their use
12/05/2001	EP1159254A1 Oxyalkylene-substituted aminophenol intermediate
12/05/2001	EP1159252A1 Method for the racemization of optically active amines
12/05/2001	EP1146035A9 Crystal polymorphism of aminoethylphenoxyacetic acid derivative
12/05/2001	EP0839150B1 Process for the preparation of ruthenium hydrogenation catalysts and products thereof
12/05/2001	EP0805143B1 Organic electroluminescent element, organic thin film, and triamine compounds
12/04/2001	US6326369 Bicyclic quinone compounds, their production and use
12/04/2001	US6326027 Solid, oral dosage form, comprising tramadol or its salt in matrix providing at least twelve hour effectiveness
11/2001
11/29/2001	US20010047112 Stable aromatic amine composition, a process for preparing color stable aromatic amines, and the production of light colored aromatic amine-based polyether polyols
11/29/2001	DE10025238A1 Verwendung substituierter 1-Amino-5-phenylpentan-3-ol- und/oder 1-Amino-6-phenylhexan-3-ol- Verbindungen als Arzneimittel Use of substituted 1-amino-5-phenylpentane-3-ol and / or 1-amino-6-phenylhexane-3-ol compounds as medicaments
11/28/2001	EP1158008A2 Curable hybrid electron donor compounds containing vinyl ether
11/28/2001	EP0906268B1 Alkyloxyamino substituted fluorenones and their use as protein kinase c inhibitors
11/27/2001	US6323369 As analgesics
11/27/2001	US6323368 Resolving racemic tramadol by classical salt resolution using a substantially single enantiomer of o,o-di-p-toluoyltartaric acid as a resolving agent
11/27/2001	US6323366 Arylamine synthesis
11/22/2001	WO2001087866A1 Cyclohexyl derivatives and their use as therapeutic agents
11/22/2001	WO2001087818A1 Method for producing arylpoly(oxalkyl)-benzyldimethyl-ammonium derivatives
11/22/2001	WO2001087299A1 Aralkyl ester soft drugs
11/22/2001	WO2001087293A1 -secretase inhibitors
11/22/2001	US20010044471 Hydrogenation of racemic 6-alkoxy-1H-indene-1,2(3H)-dione-2-oxime, with chiral acid, resolution, alkylation, bromination, carboxamidation
11/22/2001	US20010044404 Cleaning process and composition
11/22/2001	DE10023955A1 Preparation of bactericidal and fungicidal aryl poly(oxalkyl) benzyldimethylammonium derivatives is by reaction of arylpoly(oxalkyl) compounds with optionally substituted benzyldimethylamine in a solvent
11/22/2001	CA2410077A1 Cyclohexyl derivatives and their use as therapeutic agents
11/22/2001	CA2407099A1 Aralkyl ester soft drugs
11/22/2001	CA2407088A1 Beta-secretase inhibitors
11/22/2001	CA2401588A1 Preparation of arylpoly(oxalkyl)benzyldimethylammonium derivatives
11/21/2001	EP1156049A1 Substituted heterocyclic compounds, their process of preparation and pharmaceutical compositions containing them
11/21/2001	EP1154984A1 Inhibitors for uptake of serotonine, dopamine or norepinephrine
11/21/2001	EP1154983A1 Novel substituted 3-phenoxy and 3-phenylalkyloxy-2-phenyl-propylamines
11/21/2001	CN1323289A Aminoalcohol derivatives and their use as beta 3 adrenergic agonists
11/21/2001	CN1075075C Preparation and use of (3-alkoxyphenyl) magnesium chlorides
11/20/2001	US6320081 Suitable for preparation of selected o-aminophenols or o-aminothiophenols of high isomer purity and stability to oxidation; monomers for preparation of polybenzothiazole or polybenzoxazole precursors
11/20/2001	US6320017 Polyamide oligomers
11/18/2001	CA2347901A1 Curable hybrid electron donor compounds containing vinyl ether
11/15/2001	WO2001008672A3 Glucamine compounds for treating hepatitis virus infections
11/15/2001	US20010041778 Method of polymerization
11/14/2001	CN1321639A Substd. heterocyclic compounds, preparing process thereof and pharmaceutical composition contg them
11/14/2001	CN1321634A Substd heterocyclic compounds preparing method thereof and pharmaceutical composition contg. them
11/14/2001	CN1321633A Synthesis of substd amine
11/14/2001	CN1074763C Process for preparing esmolol hydrochloride
11/13/2001	US6316672 Form a of fluoxetine hydrochloride
11/13/2001	US6316658 Quinolone carboxylate chemical intermediates; microbiocides, bactericides
11/13/2001	US6316555 For synthesizing a block copolymer, stability
11/13/2001	CA2171728C Triaryl-ethylene derivatives for use in therapy
11/08/2001	WO2001083807A1 Resolution of aminotetralins
11/08/2001	WO2001083422A1 Process for the separation of the cis trans diastereoisomers of tramadol
11/08/2001	WO2000017133A3 Lta4 hydrolase inhibitors
11/08/2001	EP1144348A3 Lta 4? hydrolase inhibitors
11/08/2001	CA2407776A1 Resolution of aminotetralins
11/07/2001	EP1150942A1 Improved compounds for protein binding
11/07/2001	EP1150941A1 Method for the racemization of optically active amines
11/07/2001	EP1003711B1 Novel lipopolyamines, and the preparation and use thereof
11/07/2001	EP0931055B1 Selective alkylation of an alcohol substituted phenol compound
11/07/2001	EP0626939B1 Tri-substituted phenyl derivatives as phosphodiesterase inhibitors
11/06/2001	US6313350 Form a of fluoxetine hydrochloride
11/06/2001	US6313349 Electroluminescent intermediate
11/06/2001	US6313177 As antiviral agents
11/06/2001	US6313146 Calcium receptor-active molecules
11/06/2001	US6313139 Administering benzylamine derivative for therapy of psychiatric disorder in mammals
11/06/2001	US6313132 Therapeutically active diarylpropylamines; their pharmaceutically acceptable salts; a method for their preparation and method for their use
11/01/2001	WO2001081424A1 Monoclonal antibody antagonists for treating medical problems associated with d-amphetamine-like drugs
11/01/2001	WO2001081295A1 Cyclohexylamine derivative as subtype selective nmda receptor antagonists
11/01/2001	US20010036477 Oral administering
11/01/2001	CA2406272A1 Cyclohexylamine derivative as subtype selective nmda receptor antagonists
10/2001
10/31/2001	EP0902780B1 Quaternary cytofectins
10/31/2001	EP0784621B1 Quinidine conjugates and their use in immunoassays
10/31/2001	EP0717620B1 Substituted 2-aminotetralins
10/31/2001	CN1320114A New derivatives of 6-(4-phenylbutoxy) hexylamine and process for producing salmeterol
10/31/2001	CN1073984C A process for the preparation of 5,6-dihydroxy-2-amino-1,2,3,4-tetrahydronapht-halene derivatives
10/30/2001	US6310252 As topical anaesthetics
10/30/2001	US6310251 Form a of fluoxetine hydrochloride
10/30/2001	US6310250 Form A of fluoxetine hydrochloride
10/30/2001	US6310248 Process and intermediates
10/30/2001	US6310238 Intermediates for the preparation of polybenzoxazoles and polybenzothiazoles
10/30/2001	US6310107 (+)-6-(4-biphenylyl)methoxy-2-(2-(n,n-dimethylamino)ethyl)tetr alin, or a salt is useful for inhibiting production and/or secretion of amyloid-beta protein
10/25/2001	US20010034454 Description anti-mitotic agents which inhibit tubulin polymerization
10/25/2001	US20010034371 Antidiabetic agents
10/25/2001	US20010033944 Light-emitting material for organo-electroluminescence device and for organic electroluminescence device which the material is applied
10/24/2001	EP1147401A1 Reaction monitoring
10/24/2001	CN1318536A Substituted biphenyl oxazoline

1 ... 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 ... 140